These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26770629)

  • 1. Human mutL homolog 1 expression characteristic and prognostic effect on patients with sporadic colorectal cancer.
    Pu C; Ren W; Sun Z; Yu X; Yuan W; Huang M; Shen S; Wang X
    Int J Clin Exp Med; 2015; 8(10):19652-61. PubMed ID: 26770629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of mismatch repair gene expression in sporadic colorectal cancer.
    Sun Z; Yu X; Wang H; Zhang S; Zhao Z; Xu R
    Exp Ther Med; 2014 Nov; 8(5):1416-1422. PubMed ID: 25289032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression difference of DNA mismatch repair gene hMLH1 and hMSH2 between schistosomiasis-associated colorectal cancer and sporadic colorectal cancer].
    Chen Y; Liu Z; Qian J; Feng H; Li D; Fan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jan; 19(1):75-9. PubMed ID: 26797844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic and prognostic values of repair protein hMLH1, hMSH2 and protein CD34 immunoexpression in sporadic colorectal cancer].
    Słomka M; Stasikowska O; Wagrowska-Danilewicz M; Danilewicz M; Małecka-Panas E
    Pol Merkur Lekarski; 2010 Dec; 29(174):351-6. PubMed ID: 21298983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and significance of mismatch repair genes hMLH1 and hMSH2 in sporadic colorectal carcinoma].
    Zheng JY; Ren TS; Liu B; Wang MN; Liao HH
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):590-4. PubMed ID: 21122410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of hMLH1 or hMSH2 expression as a stage-dependent prognostic factor in sporadic colorectal cancers.
    Park JW; Chang HJ; Park S; Kim BC; Kim DY; Baek JY; Kim SY; Oh JH; Choi HS; Park SC; Jeong SY
    Ann Surg Oncol; 2010 Nov; 17(11):2839-46. PubMed ID: 20549564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between hMLH1/hMSH2 and p53 protein expression in sporadic colorectal cancer.
    Park IJ; Kim HC; Kim JS; Yu ES; Yu CS; Kim JC
    Hepatogastroenterology; 2005; 52(62):450-4. PubMed ID: 15816455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma.
    Tzao C; Hsu HS; Sun GH; Lai HL; Wang YC; Tung HJ; Yu CP; Cheng YL; Lee SC
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1371. PubMed ID: 16256791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of hMLH1 and p53 immunohistochemical status in right-sided colon cancer.
    Smyth EF; Sharma A; Sivarajasingham N; Hartley J; Monson JR; Cawkwell L
    Dis Colon Rectum; 2004 Dec; 47(12):2086-91; discussion 2091-2. PubMed ID: 15657659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation of hMLH1 and p16INK4a in Tunisian patients with sporadic colorectal adenocarcinoma.
    Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Frikha F; Kallel L; Frikha M; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
    Biosci Rep; 2011 Aug; 31(4):257-64. PubMed ID: 20815811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of hMLH1 in sporadic human colorectal cancer tumors and distant metastases.
    Larsen NB; Heiberg Engel PJ; Rasmussen M; Rasmussen LJ
    APMIS; 2009 Nov; 117(11):839-48. PubMed ID: 19845535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of microsatellite instability, MLH1 expression and hMLH1 promoter hypermethylation in colorectal carcinomas among Tunisians patients.
    Kria Ben Mahmoud L; Arfaoui A; Khiari M; Chaar I; Lounis A; Sammoud S; Ben Hmida AM; Gharbi L; Mzabi SR; Bouraoui S
    Tunis Med; 2012; 90(8-9):646-53. PubMed ID: 22987381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
    Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
    Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hMLH1, hMSH2 and cyclooxygenase-2 (cox-2) in sporadic colorectal polyps.
    Balbinotti RA; Ribeiro U; Sakai P; Safatle-Ribeiro AV; Balbinotti SS; Scapulatempo C; Alves VA; Corbett CE; Carrilho FJ
    Anticancer Res; 2007; 27(6C):4465-71. PubMed ID: 18214062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer.
    Deng G; Bell I; Crawley S; Gum J; Terdiman JP; Allen BA; Truta B; Sleisenger MH; Kim YS
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):191-5. PubMed ID: 14734469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas.
    Hawkins NJ; Ward RL
    J Natl Cancer Inst; 2001 Sep; 93(17):1307-13. PubMed ID: 11535705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathology and mismatch repair status of 458 consecutive colorectal carcinomas.
    Wright CL; Stewart ID
    Am J Surg Pathol; 2003 Nov; 27(11):1393-406. PubMed ID: 14576472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related alteration in the association of microsatellite instability with absent hMLH1 expression and histological types of colorectal carcinoma.
    Arai T; Sugai T; Kasahara I; Sawabe M; Honma N; Aida J; Nakamura S; Takubo K
    Pathol Int; 2006 Oct; 56(10):597-603. PubMed ID: 16984616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of hMLH1 and hMSH2 expression in cisplatin-treated ovarian cancer patients.
    Magnowska M; Surowiak P; Nowak-Markwitz E; Michalak M; Magnowski P; Rokita W; Kedzia H; Zabel M; Spaczyński M
    Ginekol Pol; 2008 Dec; 79(12):826-34. PubMed ID: 19175039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of hMLH1 expression is associated with less aggressive clinicopathological features in sporadic endometrioid endometrial adenocarcinoma.
    Ju W; Park HM; Lee SN; Sung SH; Kim SC
    J Obstet Gynaecol Res; 2006 Oct; 32(5):454-60. PubMed ID: 16984511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.